Viridian Therapeutics
VRDN
VRDN
44 hedge funds and large institutions have $46.1M invested in Viridian Therapeutics in 2017 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
20% less capital invested
Capital invested by funds: $57.4M → $46.1M (-$11.3M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
44
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.82M | |
| 2 | +$915K | |
| 3 | +$609K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$490K |
| 5 |
BlackRock
New York
|
+$305K |
Top Sellers
| 1 | -$1.58M | |
| 2 | -$302K | |
| 3 | -$38.5K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$28.2K |
| 5 |
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
|
-$25.6K |